The therapeutic potential of ribozymes.

Ribozymes are catalytic RNA molecules that recognize their target RNA in a highly sequence-specific manner. They can therefore be used to inhibit deleterious gene expression (by cleavage of the target mRNA) or even repair mutant cellular RNAs. Targets such as the mRNAs of oncogenes (resulting from base mutations or chromosome translocations, eg, ras or bcr-abl) and viral genomes and transcripts (human immunodeficiency virus-type 1 [HIV-1]) are ideal targets for such sequence-specific agents. The aim of this review is therefore to introduce the different classes of ribozymes, highlighting some of the chemistry of the reactions they catalyze, to address the specific inhibition of genes by ribozymes, the problems yet to be resolved, and how new developments in the field give hope to the future for ribozymes in the therapeutic field.

[1]  Michael Zuker,et al.  Some simple computational methods to improve the folding of large RNAs , 1984, Nucleic Acids Res..

[2]  C. Kundrot,et al.  Crystal Structure of a Group I Ribozyme Domain: Principles of RNA Packing , 1996, Science.

[3]  R. Symons,et al.  Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites , 1987, Cell.

[4]  J. Whitton,et al.  Ribozymes which cleave arenavirus RNAs: identification of susceptible target sites and inhibition by target site secondary structure , 1992, Journal of virology.

[5]  H. Kijima,et al.  Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. , 1996, Nucleic acids research.

[6]  H. Robertson,et al.  Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Cech,et al.  One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity , 1986, Cell.

[8]  R. Symons,et al.  Structure, self-cleavage, and replication of two viroid-like satellite RNAs (virusoids) of subterranean clover mottle virus. , 1990, Virology.

[9]  E. Kyle,et al.  Inhibition of protein-tyrosine kinase activity in intact cells by the aptameric action of oligodeoxynucleotides. , 1995, Antisense research and development.

[10]  S. B. Wilson,et al.  Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia. , 1993, Experimental hematology.

[11]  P. J. Welch,et al.  A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection. , 1996, Gene therapy.

[12]  B. Sjöberg,et al.  Metal ion interaction with cosubstrate in self-splicing of group I introns. , 1997, Nucleic acids research.

[13]  John M. Burke,et al.  Binding and cleavage of nucleic acids by the "hairpin" ribozyme. , 1991, Biochemistry.

[14]  M. Blumenfeld,et al.  BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism. , 1995, Blood.

[15]  H. Robertson,et al.  Cell-free synthesis and processing of an infectious dimeric transcript of potato spindle tuber viroid RNA. , 1985, Virology.

[16]  A. Pollock,et al.  Matrix Metalloproteinase 2 (Gelatinase A) Regulates Glomerular Mesangial Cell Proliferation and Differentiation* , 1996, The Journal of Biological Chemistry.

[17]  T. Cech,et al.  Ribozyme-mediated repair of defective mRNA by targeted trans-splicing , 1994, Nature.

[18]  T. Cech,et al.  New reactions of the ribosomal RNA precursor of Tetrahymena and the mechanism of self-splicing. , 1986, Journal of molecular biology.

[19]  M. Kay,et al.  Adenovirus-mediated expression of ribozymes in mice , 1996, Journal of virology.

[20]  J. Yee,et al.  Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. , 1994, Gene therapy.

[21]  M. Yarus.  How many catalytic RNAs? Ions and the Cheshire cat conjecture , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  B. Stoddard,et al.  Capturing the Structure of a Catalytic RNA Intermediate: The Hammerhead Ribozyme , 1996, Science.

[23]  Joshua T. Jones,et al.  Tagging ribozyme reaction sites to follow trans–splicing in mammalian cells , 1996, Nature Medicine.

[24]  T. Nyholm,et al.  Reduced beta 2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme. , 1994, Nucleic acids research.

[25]  T L Beattie,et al.  A long‐range pseudoknot is required for activity of the Neurospora VS ribozyme. , 1996, The EMBO journal.

[26]  P. Iversen,et al.  Pharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections. , 1996, The Journal of pharmacology and experimental therapeutics.

[27]  E. Reddy,et al.  Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia. , 1996, Leukemia & lymphoma.

[28]  S. Altman,et al.  Metal ion requirements and other aspects of the reaction catalyzed by M1 RNA, the RNA subunit of ribonuclease P from Escherichia coli. , 1986, Biochemistry.

[29]  M. Mörl,et al.  Integration of group II intron bl1 into a foreign RNA by reversal of the self-splicing reaction in vitro , 1990, Cell.

[30]  E. Kandel,et al.  Control of Memory Formation Through Regulated Expression of a CaMKII Transgene , 1996, Science.

[31]  H. Kijima,et al.  Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymes. , 1996, The Journal of investigative dermatology.

[32]  R. Pictet,et al.  Visualization of the interaction of a regulatory protein with RNA in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Jarvis,et al.  Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Cech,et al.  Mechanism of recognition of the 5′ splice site in self-splicing group I introns , 1986, Nature.

[35]  P. Yaswen,et al.  Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. , 1993, Antisense research and development.

[36]  Tom Maniatis,et al.  The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing , 1987, Nature.

[37]  J. Davies,et al.  Antibiotic inhibition of group I ribozyme function , 1991, Nature.

[38]  W. Gerlach,et al.  Simple RNA enzymes with new and highly specific endoribonuclease activities , 1988, Nature.

[39]  D. Atkins,et al.  Artificial ribozyme and antisense gene expression in Saccharomyces cerevisiae. , 1994, Antisense research and development.

[40]  R. Waring,et al.  Base pairing between the 3' exon and an internal guide sequence increases 3' splice site specificity in the Tetrahymena self-splicing rRNA intron , 1990, Molecular and cellular biology.

[41]  M. Nerenberg,et al.  A hammerhead ribozyme cleaves its target RNA during RNA preparation. , 1996, Antisense & nucleic acid drug development.

[42]  H. Robertson,et al.  A replication cycle for viroids and other small infectious RNA's. , 1984, Science.

[43]  M. Rosbash,et al.  Efficient trans-splicing of a yeast mitochondrial RNA group II intron implicates a strong 5' exon-intron interaction. , 1986, Science.

[44]  W. James,et al.  Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. , 1993, Nucleic acids research.

[45]  D. Herschlag,et al.  Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Butcher,et al.  Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. , 1993, The EMBO journal.

[47]  T. Herget,et al.  Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo. , 1992, The EMBO journal.

[48]  J. Rossi,et al.  Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. T. Perrotta,et al.  A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA , 1991, Nature.

[50]  M. Lai,et al.  Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. , 1992, Journal of molecular biology.

[51]  R. Tritz,et al.  RNA catalytic properties of the minimum (-)sTRSV sequence. , 1989, Biochemistry.

[52]  Cleavage by RNase P of Gene N mRNA Reduces Bacteriophage λ Burst Size , 1996 .

[53]  G. Sczakiel,et al.  Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes. , 1996, Journal of molecular biology.

[54]  W. Haseltine,et al.  Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. , 1992, Virology.

[55]  J. D. Thompson,et al.  Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter. , 1995, Nucleic acids research.

[56]  T. Cech,et al.  Conformational switches involved in orchestrating the successive steps of group I RNA splicing. , 1996, Biochemistry.

[57]  E. Westhof,et al.  A three-dimensional model for the hammerhead ribozyme based on fluorescence measurements. , 1994, Science.

[58]  R. Schroeder,et al.  Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. , 1996, Journal of molecular biology.

[59]  V. A. Flørenes,et al.  Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. , 1994, Cancer research.

[60]  Reaction conditions and kinetics of self-cleavage of a ribozyme derived from Neurospora VS RNA. , 1993, Biochemistry.

[61]  C. Hernández,et al.  Plus and minus RNAs of peach latent mosaic viroid self-cleave in vitro via hammerhead structures. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[62]  E. Cantin,et al.  In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA. , 1993, Leukemia.

[63]  F. Eckstein,et al.  Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. , 1991, Science.

[64]  J. Rossi,et al.  Ribozymes as potential anti-HIV-1 therapeutic agents. , 1990, Science.

[65]  J. Perreault,et al.  The RNA of both polarities of the peach latent mosaic viroid self-cleaves in vitro solely by single hammerhead structures. , 1995, Nucleic acids research.

[66]  O. Uhlenbeck,et al.  Inhibition of the hammerhead ribozyme by neomycin. , 1969, RNA.

[67]  R. Collins,et al.  A secondary-structure model for the self-cleaving region of Neurospora VS RNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  T. Cech,et al.  Joining the Two Domains of a Group I Ribozyme to Form the Catalytic Core , 1997, Science.

[69]  The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes. , 1994, Nucleic acids research.

[70]  H. Prydz,et al.  A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo. , 1995, The EMBO journal.

[71]  Mechanistic investigations of a ribozyme derived from the Tetrahymena group I intron: insights into catalysis and the second step of self-splicing. , 1996, Biochemistry.

[72]  K. Jarrell,et al.  Use of engineered ribozymes to catalyze chimeric gene assembly. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Y. Suh,et al.  Constructing an efficient trans‐acting genomic HDV ribozyme , 1996, FEBS letters.

[74]  A. P. Williams,et al.  Evidence that alternate foldings of the hepatitis delta RNA confer varying rates of self-cleavage. , 1994, Biochemistry.

[75]  R. Wagner.  Gene inhibition using antisense oligodeoxynucleotides , 1994, Nature.

[76]  J. Gall,et al.  Self-cleaving transcripts of satellite DNA from the newt , 1987, Cell.

[77]  R Cedergren,et al.  Numbering system for the hammerhead. , 1992, Nucleic acids research.

[78]  M. Nassal,et al.  Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. , 1995, Nucleic acids research.

[79]  E. Kyle,et al.  Aptameric inhibition of p210bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure. , 1994, Nucleic acids research.

[80]  R. Collins,et al.  A site-specific self-cleavage reaction performed by a novel RNA in neurospora mitochondria , 1990, Cell.

[81]  J. Rossi,et al.  Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition. , 1996, Antisense & nucleic acid drug development.

[82]  Antibiotic interactions with the hammerhead ribozyme:tetracyclines as a new class of hammerhead inhibitor. , 1996, The Biochemical journal.

[83]  W. Gerlach,et al.  A ribozyme that enhances gene suppression in tobacco protoplasts. , 1993, Antisense research and development.

[84]  G. Hobom,et al.  Ribozyme mediated destruction of influenza A virus in vitro and in vivo , 1994, Journal of medical virology.

[85]  J. Finke,et al.  Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs , 1994, FEBS letters.

[86]  T. Cech,et al.  Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. , 1993, Science.

[87]  N. Pace,et al.  The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme , 1983, Cell.

[88]  D. Atkins,et al.  The ade6 gene of the fission yeast as a target for antisense and ribozyme RNA-mediated suppression. , 1995, Antisense research and development.

[89]  G. Sczakiel,et al.  A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design. , 1994, Nucleic acids research.

[90]  E. Reddy,et al.  Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias. , 1995, Blood.

[91]  P. Waterhouse,et al.  A satellite RNA of barley yellow dwarf virus contains a novel hammerhead structure in the self-cleavage domain. , 1991, Virology.

[92]  A Klug,et al.  The crystal structure of an all-RNA hammerhead ribozyme. , 1995, Nucleic acids symposium series.

[93]  A. Banerjea,et al.  Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates. , 1992, Nucleic acids research.

[94]  A. Pyle,et al.  Two competing pathways for self-splicing by group II introns: a quantitative analysis of in vitro reaction rates and products. , 1996, Journal of molecular biology.

[95]  T. Cech,et al.  In vitro splicing of the ribosomal RNA precursor of tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence , 1981, Cell.

[96]  R. Symons,et al.  Self-cleavage of plus and minus RNA transcripts of avocado sunblotch viroid. , 1986, Nucleic acids research.

[97]  M. Lai,et al.  A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication , 1996, Journal of virology.

[98]  S. Sigurdsson,et al.  Structure-function relationships of hammerhead ribozymes: from understanding to applications. , 1995, Trends in biotechnology.

[99]  McIntyre Cl,et al.  Strategies for the suppression of peroxidase gene expression in tobacco. II. In vivo suppression of peroxidase activity in transgenic tobacco using ribozyme and antisense constructs. , 1996 .

[100]  J. M. Buzayan,et al.  Non-enzymatic cleavage and ligation of RNAs complementary to a plant virus satellite RNA , 1986, Nature.

[101]  A. Lamond,et al.  Nuclease resistant ribozymes with high catalytic activity. , 1992, The EMBO journal.

[102]  J. Rossi,et al.  Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. , 1994, Gene.

[103]  A. Wellstein,et al.  Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[104]  G. F. Joyce,et al.  In vitro evolution of nucleic acids. , 1994, Current opinion in structural biology.

[105]  T. Dorai,et al.  Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. , 1994, Cancer research.

[106]  G. Sczakiel,et al.  The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells. , 1997, Nucleic acids research.

[107]  E. Reddy,et al.  Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. , 1993, Oncogene.

[108]  J. Rossi,et al.  The potential use of catalytic RNAs in therapy of HIV infection and other diseases. , 1991, Pharmacology & therapeutics.

[109]  R. A. Collins,et al.  Efficient trans‐cleavage of a stem‐loop RNA substrate by a ribozyme derived from neurospora VS RNA. , 1995, The EMBO journal.

[110]  M. Lai,et al.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[111]  H. Lodish.  Molecular Cell Biology , 1986 .

[112]  P. A. Jennings,et al.  Multiple domains in a ribozyme construct confer increased suppressive activity in monkey cells. , 1994, Antisense research and development.

[113]  K. Flaherty,et al.  Three-dimensional structure of a hammerhead ribozyme , 1994, Nature.

[114]  M. Brach,et al.  Ribozyme‐mediated cleavage of the MDR‐1 transcript restores chemosensitivity in previously resistant cancer cells , 1994, The EMBO journal.

[115]  W. P. Rindone,et al.  Computer-aided prediction of RNA secondary structures , 1982, Nucleic Acids Res..

[116]  J. Rossi,et al.  Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. , 1993, Blood.

[117]  J. M. Buzayan,et al.  Autolytic Processing of Dimeric Plant Virus Satellite RNA , 1986, Science.

[118]  D. Engelke,et al.  Expression of small, therapeutic RNAs in human cell nuclei , 1997, Gene Therapy.

[119]  M. Kay,et al.  Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes , 1996, Journal of virology.

[120]  P. Perlman,et al.  A self-splicing RNA excises an intron lariat , 1986, Cell.

[121]  S. Read,et al.  Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme , 1991, Journal of virology.

[122]  T. Cech,et al.  Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena , 1982, Cell.

[123]  L. Pick,et al.  Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila , 1993, Nature.

[124]  N. Pace,et al.  The varieties of ribonuclease P. , 1992, Trends in biochemical sciences.

[125]  N. Sakamoto,et al.  Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. , 1996, The Journal of clinical investigation.

[126]  A. Krieg,et al.  Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. , 1994, Antisense research and development.

[127]  M. Sioud.  Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates. , 1997, Nucleic acids research.

[128]  H. Lipshitz,et al.  Localized RNAs and their functions , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[129]  M. D. Been.  Cis- and trans-acting ribozymes from a human pathogen, hepatitis delta virus. , 1994, Trends in biochemical sciences.

[130]  Arnold E. Hampel,et al.  Catalytic properties of hairpin ribozymes derived from Chicory yellow mottle virus and arabis mosaic virus satellite RNAs. , 1995, Biochemistry.

[131]  O. Uhlenbeck,et al.  Role of divalent metal ions in the hammerhead RNA cleavage reaction. , 1991, Biochemistry.

[132]  Enhancement of Neurospora VS ribozyme cleavage by tuberactinomycin antibiotics. , 1995, The EMBO journal.

[133]  J W Szostak,et al.  In vitro selection of catalytic RNAs. , 1994, Current opinion in structural biology.

[134]  F. Wong-Staal,et al.  Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial. , 1996, Gene Therapy.

[135]  R. Pictet,et al.  The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. , 1997, RNA.

[136]  J. Lawrence,et al.  Intracellular localization of messenger RNAs for cytoskeletal proteins , 1986, Cell.

[137]  S. Altman,et al.  Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease P. , 1994, Science.